Serological response to three alternative series of hepatitis B revaccination Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial

Stijn F. H. Raven*, Christian J. P. A. Hoebe, Ann C. T. M. Vossen, Leo G. Visser, Jeannine L. A. Hautvast, Anna H. E. Roukens, Jim E. van Steenbergen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)92-101
Number of pages10
JournalLancet Infectious Diseases
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • VACCINE
  • IMMUNOGENICITY
  • IMMUNIZATION
  • EFFICACY

Cite this